Abstract:Abstract 4-Androstene-3,17-dione (4-AD), 1,4-androstadiene-3,17-dione (ADD) and 9α-hydroxyl-4-androstene-3,17-dione (9OH-AD), which are important starting compounds for the synthesis of steroidal medicines, can be biosynthetically transformed from phytosterols by Mycobacterium strains. Genomic and metabolic analyses have revealed that currently available 4-AD-producing strains maintain the ability to convert 4-AD to ADD and 9OH-AD via 3-ketosteroid-1,2-dehydrogenase (KstD) and 3-ketosteroid-9α-hydroxylase (Ksh), not only lowering the production yield of 4-AD but also hampering its purification refinement. Additionally, these 4-AD industrial strains are excellent model strains to construct ADD- and 9OH-AD-producing strains. We recently found that Mycobacterium neoaurum HGMS2, a 4-AD-producing strain, harbored fewer kstd and ksh genes through whole-genomic and enzymatic analyses, compared with other strains (Wang et al. in Microbial Cell Fact 19:187, 2020). In this study, we attempted to construct an efficient 4-AD-producing strain by knocking out the kstd and ksh genes from the M. neoaurum HGMS2 strain. Next, we used kstd - and ksh -default HGMS2 mutants as templates to construct ADD- and 9OH-AD-producing strains by knocking in active kstd and ksh genes, respectively. We found that after knocking out its endogenous kstd and ksh genes, one of these knockout mutants, HGMS2 Δkstd211 + ΔkshB122 , showed a 20% increase in the rate of phytosterol to 4-AD conversion, compared relative to the wild-type strain and an increase in 4-AD yield to 38.3 g/L in pilot-scale fermentation. Furthermore, we obtained the ADD- and 9OH-AD-producing strains, HGMS2 kstd2 + Δkstd211+ΔkshB122 and HGMS2 kshA51 + Δkstd211+ΔkshA226 , by knocking in heterogenous active kstd and ksh genes to selected HGMS2 mutants, respectively. During pilot-scale fermentation, the conversion rates of the ADD- and 9OH-AD-producing mutants transforming phytosterol were 42.5 and 40.3%, respectively, and their yields reached 34.2 and 37.3 g/L, respectively. Overall, our study provides efficient strains for the production of 4-AD, ADD and 9OH-AD for the pharmaceutical industry and provides insights into the metabolic engineering of the HGMS2 strain to produce other important steroidal compounds.

Construction of genetically engineered strain for bioconversion of progesterone

Production of 17α-hydroxyprogesterone using an engineered biocatalyst with efficient electron transfer and improved 5-aminolevulinic acid synthesis coupled with a P450 hydroxylase

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Light-driven progesterone production by InP–(M. neoaurum) biohybrid system

Enhanced Biocatalytic Production of Cortisol by Protein Engineering and Process Engineering

Functional reconstitution of a steroidal hydroxylase from the fungus Thanatephorus cucumeris in Mycolicibacterium neoaurum for 15α-hydroxylation of progesterone

Heterologous erythromycin production across strain and plasmid construction

Manipulation of sterol homeostasis for the production of 24-epi-ergosterol in industrial yeast

Pregnenolone and progesterone production from natural sterols using recombinant strain of Mycolicibacterium smegmatis mc2 155 expressing mammalian steroidogenesis system

Conjugational Delivery of Chromosomal Integrative Constructs for Gene Expression in the Carbendazim-Degrading Rhodococcus Erythropolis D-1

Transformation of phytosterols into pregnatetraenedione by a combined microbial and chemical process

Improvement on the Key Synthesis Process of Progesterone

Construction of A Novel Recombinant Escherichia Coli Strain Capable of Producing 1,3-Propanediol

Efficient production of 22(R)‐hydroxycholesterol via combination optimization of Saccharomyces cerevisiae

Rerouting phytosterol degradation pathway for directed androst-1,4-diene-3,17-dione microbial bioconversion

Engineering endogenous l-proline biosynthetic pathway to boost trans-4-hydroxy-l-proline production in Escherichia coli

Construction of an alkaline protease overproducer strain based on Bacillus licheniformis 2709 using an integrative approach

Single-Stage Bioconversion of Phytosterol into Testosterone by Recombinant Strains of Mycolicibacterium neoaurum

Construction of a Cell Factory for the Targeted and Efficient Production of Phytosterol to Boldenone in Mycobacterium neoaurum

Efficient conversion of phytosterols into 4-androstene-3,17-dione and its C1,2-dehydrogenized and 9α-hydroxylated derivatives by engineered Mycobacteria

Co-biosynthesis of 3-Hydroxypropionic Acid and 1,3-Propanediol by a Newly Isolated Lactobacillus Reuteri Strain During Whole Cell Biotransformation of Glycerol